• Vaxil Locations
  • Contact Us
  • Subscribe
Vaxil Bio
  • About Vaxil
  • TEAM
  • INTELLECTUAL PROPERTY
  • News and Updates
  • In the Media
  • 2025 Shareholder Meeting Material

Public Filings

TO DOWNLOAD, PLEASE CLICK BELOW.

2022

Financial Statements (March 31)

Management Discussion and Analysis (March 31)

2021

Financial Statements (December 31)

Management Discussion and Analysis (December 31)

Financial Statements (September 30)

Management Discussion and Analysis (September 30)

Financial Statements (March 31)

Management Discussion and Analysis (March 31)

2020

Financial Statements (December 31)

Management Discussion and Analysis (December 31)

Financial Statements (September 30)

Management Discussion and Analysis (September 30)

Financial Statements (June 30)

Management Discussion and Analysis (June 30)

Financial Statements (March 31)

Management Discussion and Analysis (March 31)

2019

Financial Statements (December 31)

Management Discussion and Analysis (December 31)

Financial Statements (September 30)

Management Discussion and Analysis (September 30)

Financial Statements (June 30)

Management Discussion and Analysis (June 30)

Financial Statements (March 31)

Management Discussion and Analysis (March 31)

2018

Financial Statements (December 31)

Management Discussion and Analysis (December 31)

2017

Financial Statements (December 31)

Management Discussion and Analysis (December 31)

Vaxil Canada
First Canadian Place, 34th Floor, 100 King Street W., Toronto, Ontario. M2N 6N4 Canada

Vaxil Israel
3 Pinhas Sapir Street, 3rd Floor, Weizmann Science Park, 74140, Rehovot, Israel

Corporate

  • Home
  • About Vaxil
  • Vaxil Locations
  • Contact Us
  • Board & Executives
  • News and Updates

INVESTORS

  • Investor Presentations
  • Public Filings
  • News and Updates
  • In the Media
  • Video
  • Scientific Publications
Copyright 2025 © VAXIL BIO THERAPEUTICS | Vaxil Bio therapeutics is an Israeli biotech focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil is listed on the TSX-Venture as VXL
  • About Vaxil
  • TEAM
  • INTELLECTUAL PROPERTY
  • News and Updates
  • In the Media
  • 2025 Shareholder Meeting Material
  • Vaxil Locations
  • Contact Us
  • Subscribe